What's at Stake: Understanding Medicaid Drug Pricing Deals The Trump administration has announced a new initiative aimed at reducing prescription medication costs for millions of Americans relying on Medicaid.
The deal, affecting nine major pharmaceutical firms, marks a significant shift in the federal government's approach to negotiating lower prices with industry leaders.
The Context: Understanding Medicaid and Drug Pricing Medicaid is the largest public health insurance program in the United States, covering nearly 74 million low income individuals, including children, pregnant women, and people with disabilities.